EMEA (Europe, Middle East and Africa) Drug Eluting Stents (DES) Market Report 2017

October 2017 | 119 pages | ID: E86245ADEF8PEN
QYResearch

Abstracts

In this report, the EMEA Drug Eluting Stents (DES) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Drug Eluting Stents (DES) for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Drug Eluting Stents (DES) market competition by top manufacturers/players, with Drug Eluting Stents (DES) sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Abbott Vascular
• Advantec Vascular
• B.Braun Melsengen AG
• Biosensors
• Biotronik
• Blue Medical
• Boston Scientific
• DISA Vascular
• Essen
• Medtronic Vascular
• MicroPort Medical
• MIV Therapeutics
• Orbusneich
• Promed Medical
• Relisys Medical
• Reva Medical
• Sahajanand
• Sino Medical
• Sorin
• Terumo Medical

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Cobalt-chromium alloy Stents
• Magnesium alloy Stents
• Tyrosine polycarbonate Stents
• Nitinol Stents
• Platinum chromium alloy Stents
• Stainless steel Stents
• Other Materials

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Drug Eluting Stents (DES) for each application, including

• Coronary Heart Disease
• Clinical

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Drug Eluting Stents (DES) Market Report 2017

1 DRUG ELUTING STENTS (DES) OVERVIEW

1.1 Product Overview and Scope of Drug Eluting Stents (DES)
1.2 Classification of Drug Eluting Stents (DES)
  1.2.1 EMEA Drug Eluting Stents (DES) Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Drug Eluting Stents (DES) Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Cobalt-chromium alloy Stents
  1.2.4 Magnesium alloy Stents
  1.2.5 Tyrosine polycarbonate Stents
  1.2.6 Nitinol Stents
  1.2.7 Platinum chromium alloy Stents
  1.2.8 Stainless steel Stents
  1.2.9 Other Materials
1.3 EMEA Drug Eluting Stents (DES) Market by Application/End Users
  1.3.1 EMEA Drug Eluting Stents (DES) Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Coronary Heart Disease
  1.3.3 Clinical
1.4 EMEA Drug Eluting Stents (DES) Market by Region
  1.4.1 EMEA Drug Eluting Stents (DES) Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Drug Eluting Stents (DES) (2012-2022)
  1.5.1 EMEA Drug Eluting Stents (DES) Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Drug Eluting Stents (DES) Revenue and Growth Rate (2012-2022)

2 EMEA DRUG ELUTING STENTS (DES) COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Drug Eluting Stents (DES) Market Competition by Players/Manufacturers
  2.1.1 EMEA Drug Eluting Stents (DES) Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Drug Eluting Stents (DES) Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Drug Eluting Stents (DES) Sale Price by Players (2012-2017)
2.2 EMEA Drug Eluting Stents (DES) (Volume and Value) by Type/Product Category
  2.2.1 EMEA Drug Eluting Stents (DES) Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Drug Eluting Stents (DES) Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Drug Eluting Stents (DES) Sale Price by Type (2012-2017)
2.3 EMEA Drug Eluting Stents (DES) (Volume) by Application
2.4 EMEA Drug Eluting Stents (DES) (Volume and Value) by Region
  2.4.1 EMEA Drug Eluting Stents (DES) Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Drug Eluting Stents (DES) Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Drug Eluting Stents (DES) Sales Price by Region (2012-2017)

3 EUROPE DRUG ELUTING STENTS (DES) (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Drug Eluting Stents (DES) Sales and Value (2012-2017)
  3.1.1 Europe Drug Eluting Stents (DES) Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Drug Eluting Stents (DES) Revenue and Growth Rate (2012-2017)
3.2 Europe Drug Eluting Stents (DES) Sales and Market Share by Type
3.3 Europe Drug Eluting Stents (DES) Sales and Market Share by Application
3.4 Europe Drug Eluting Stents (DES) Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Drug Eluting Stents (DES) Sales Volume by Countries (2012-2017)
  3.4.2 Europe Drug Eluting Stents (DES) Revenue by Countries (2012-2017)
  3.4.3 Germany Drug Eluting Stents (DES) Sales and Growth Rate (2012-2017)
  3.4.4 France Drug Eluting Stents (DES) Sales and Growth Rate (2012-2017)
  3.4.5 UK Drug Eluting Stents (DES) Sales and Growth Rate (2012-2017)
  3.4.6 Russia Drug Eluting Stents (DES) Sales and Growth Rate (2012-2017)
  3.4.7 Italy Drug Eluting Stents (DES) Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Drug Eluting Stents (DES) Sales and Growth Rate (2012-2017)

4 MIDDLE EAST DRUG ELUTING STENTS (DES) (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Drug Eluting Stents (DES) Sales and Value (2012-2017)
  4.1.1 Middle East Drug Eluting Stents (DES) Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Drug Eluting Stents (DES) Revenue and Growth Rate (2012-2017)
4.2 Middle East Drug Eluting Stents (DES) Sales and Market Share by Type
4.3 Middle East Drug Eluting Stents (DES) Sales and Market Share by Application
4.4 Middle East Drug Eluting Stents (DES) Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Drug Eluting Stents (DES) Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Drug Eluting Stents (DES) Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Drug Eluting Stents (DES) Sales and Growth Rate (2012-2017)
  4.4.4 Israel Drug Eluting Stents (DES) Sales and Growth Rate (2012-2017)
  4.4.5 UAE Drug Eluting Stents (DES) Sales and Growth Rate (2012-2017)
  4.4.6 Iran Drug Eluting Stents (DES) Sales and Growth Rate (2012-2017)

5 AFRICA DRUG ELUTING STENTS (DES) (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Drug Eluting Stents (DES) Sales and Value (2012-2017)
  5.1.1 Africa Drug Eluting Stents (DES) Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Drug Eluting Stents (DES) Revenue and Growth Rate (2012-2017)
5.2 Africa Drug Eluting Stents (DES) Sales and Market Share by Type
5.3 Africa Drug Eluting Stents (DES) Sales and Market Share by Application
5.4 Africa Drug Eluting Stents (DES) Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Drug Eluting Stents (DES) Sales Volume by Countries (2012-2017)
  5.4.2 Africa Drug Eluting Stents (DES) Revenue by Countries (2012-2017)
  5.4.3 South Africa Drug Eluting Stents (DES) Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Drug Eluting Stents (DES) Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Drug Eluting Stents (DES) Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Drug Eluting Stents (DES) Sales and Growth Rate (2012-2017)

6 EMEA DRUG ELUTING STENTS (DES) MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Abbott Vascular
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Drug Eluting Stents (DES) Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Abbott Vascular Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Advantec Vascular
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Drug Eluting Stents (DES) Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Advantec Vascular Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 B.Braun Melsengen AG
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Drug Eluting Stents (DES) Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 B.Braun Melsengen AG Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Biosensors
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Drug Eluting Stents (DES) Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Biosensors Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Biotronik
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Drug Eluting Stents (DES) Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Biotronik Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Blue Medical
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Drug Eluting Stents (DES) Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Blue Medical Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Boston Scientific
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Drug Eluting Stents (DES) Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Boston Scientific Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 DISA Vascular
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Drug Eluting Stents (DES) Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 DISA Vascular Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Essen
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Drug Eluting Stents (DES) Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Essen Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Medtronic Vascular
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Drug Eluting Stents (DES) Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Medtronic Vascular Drug Eluting Stents (DES) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 MicroPort Medical
6.12 MIV Therapeutics
6.13 Orbusneich
6.14 Promed Medical
6.15 Relisys Medical
6.16 Reva Medical
6.17 Sahajanand
6.18 Sino Medical
6.19 Sorin
6.20 Terumo Medical

7 DRUG ELUTING STENTS (DES) MANUFACTURING COST ANALYSIS

7.1 Drug Eluting Stents (DES) Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Drug Eluting Stents (DES)

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Drug Eluting Stents (DES) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Drug Eluting Stents (DES) Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA DRUG ELUTING STENTS (DES) MARKET FORECAST (2017-2022)

11.1 EMEA Drug Eluting Stents (DES) Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Drug Eluting Stents (DES) Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Drug Eluting Stents (DES) Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Drug Eluting Stents (DES) Price and Trend Forecast (2017-2022)
11.2 EMEA Drug Eluting Stents (DES) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Drug Eluting Stents (DES) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Drug Eluting Stents (DES) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Drug Eluting Stents (DES) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Drug Eluting Stents (DES) Sales Forecast by Type (2017-2022)
11.7 EMEA Drug Eluting Stents (DES) Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Drug Eluting Stents (DES)
Figure EMEA Drug Eluting Stents (DES) Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Drug Eluting Stents (DES) Sales Volume Market Share by Type (Product Category) in 2016
Figure Cobalt-chromium alloy Stents Product Picture
Figure Magnesium alloy Stents Product Picture
Figure Tyrosine polycarbonate Stents Product Picture
Figure Nitinol Stents Product Picture
Figure Platinum chromium alloy Stents Product Picture
Figure Stainless steel Stents Product Picture
Figure Other Materials Product Picture
Figure EMEA Drug Eluting Stents (DES) Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Drug Eluting Stents (DES) by Application in 2016
Figure Coronary Heart Disease Examples
Table Key Downstream Customer in Coronary Heart Disease
Figure Clinical Examples
Table Key Downstream Customer in Clinical
Figure EMEA Drug Eluting Stents (DES) Market Size (Million USD) by Region (2012-2022)
Figure Europe Drug Eluting Stents (DES) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Drug Eluting Stents (DES) Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Drug Eluting Stents (DES) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Drug Eluting Stents (DES) Revenue (Million USD) Status and Forecast by Countries
Figure Africa Drug Eluting Stents (DES) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Drug Eluting Stents (DES) Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Drug Eluting Stents (DES) Sales Volume and Growth Rate (2012-2022)
Figure EMEA Drug Eluting Stents (DES) Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Drug Eluting Stents (DES) Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Drug Eluting Stents (DES) Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Drug Eluting Stents (DES) Sales Share by Players (2012-2017)
Figure 2016 Drug Eluting Stents (DES) Sales Share by Players
Figure 2017 Drug Eluting Stents (DES) Sales Share by Players
Figure EMEA Drug Eluting Stents (DES) Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Drug Eluting Stents (DES) Revenue (Million USD) by Players (2012-2017)
Table EMEA Drug Eluting Stents (DES) Revenue Share by Players (2012-2017)
Table 2016 EMEA Drug Eluting Stents (DES) Revenue Share by Players
Table 2017 EMEA Drug Eluting Stents (DES) Revenue Share by Players
Table EMEA Drug Eluting Stents (DES) Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Drug Eluting Stents (DES) Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Drug Eluting Stents (DES) Sales Share by Type (2012-2017)
Figure Sales Market Share of Drug Eluting Stents (DES) by Type (2012-2017)
Figure EMEA Drug Eluting Stents (DES) Sales Market Share by Type (2012-2017)
Table EMEA Drug Eluting Stents (DES) Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Drug Eluting Stents (DES) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Drug Eluting Stents (DES) by Type in 2016
Table EMEA Drug Eluting Stents (DES) Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Drug Eluting Stents (DES) Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Drug Eluting Stents (DES) Sales Share by Application (2012-2017)
Figure Sales Market Share of Drug Eluting Stents (DES) by Application (2012-2017)
Figure EMEA Drug Eluting Stents (DES) Sales Market Share by Application in 2016
Table EMEA Drug Eluting Stents (DES) Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Drug Eluting Stents (DES) Sales Share by Region (2012-2017)
Figure Sales Market Share of Drug Eluting Stents (DES) by Region (2012-2017)
Figure EMEA Drug Eluting Stents (DES) Sales Market Share in 2016
Table EMEA Drug Eluting Stents (DES) Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Drug Eluting Stents (DES) Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Drug Eluting Stents (DES) by Region (2012-2017)
Figure EMEA Drug Eluting Stents (DES) Revenue Market Share Regions in 2016
Table EMEA Drug Eluting Stents (DES) Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Drug Eluting Stents (DES) Revenue and Growth Rate (2012-2017)
Table Europe Drug Eluting Stents (DES) Sales (K Units) by Type (2012-2017)
Table Europe Drug Eluting Stents (DES) Market Share by Type (2012-2017)
Figure Europe Drug Eluting Stents (DES) Market Share by Type in 2016
Table Europe Drug Eluting Stents (DES) Sales (K Units) by Application (2012-2017)
Table Europe Drug Eluting Stents (DES) Market Share by Application (2012-2017)
Figure Europe Drug Eluting Stents (DES) Market Share by Application in 2016
Table Europe Drug Eluting Stents (DES) Sales (K Units) by Countries (2012-2017)
Table Europe Drug Eluting Stents (DES) Sales Market Share by Countries (2012-2017)
Figure Europe Drug Eluting Stents (DES) Sales Market Share by Countries (2012-2017)
Figure Europe Drug Eluting Stents (DES) Sales Market Share by Countries in 2016
Table Europe Drug Eluting Stents (DES) Revenue (Million USD) by Countries (2012-2017)
Table Europe Drug Eluting Stents (DES) Revenue Market Share by Countries (2012-2017)
Figure Europe Drug Eluting Stents (DES) Revenue Market Share by Countries (2012-2017)
Figure Europe Drug Eluting Stents (DES) Revenue Market Share by Countries in 2016
Figure Germany Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure France Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure UK Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Drug Eluting Stents (DES) Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Drug Eluting Stents (DES) Sales (K Units) by Type (2012-2017)
Table Middle East Drug Eluting Stents (DES) Market Share by Type (2012-2017)
Figure Middle East Drug Eluting Stents (DES) Market Share by Type (2012-2017)
Table Middle East Drug Eluting Stents (DES) Sales (K Units) by Applications (2012-2017)
Table Middle East Drug Eluting Stents (DES) Market Share by Applications (2012-2017)
Figure Middle East Drug Eluting Stents (DES) Sales Market Share by Application in 2016
Table Middle East Drug Eluting Stents (DES) Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Drug Eluting Stents (DES) Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Drug Eluting Stents (DES) Sales Volume Market Share by Countries in 2016
Table Middle East Drug Eluting Stents (DES) Revenue (Million USD) by Countries (2012-2017)
Table Middle East Drug Eluting Stents (DES) Revenue Market Share by Countries (2012-2017)
Figure Middle East Drug Eluting Stents (DES) Revenue Market Share by Countries (2012-2017)
Figure Middle East Drug Eluting Stents (DES) Revenue Market Share by Countries in 2016
Figure Saudi Arabia Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Drug Eluting Stents (DES) Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Drug Eluting Stents (DES) Sales (K Units) by Type (2012-2017)
Table Africa Drug Eluting Stents (DES) Sales Market Share by Type (2012-2017)
Figure Africa Drug Eluting Stents (DES) Sales Market Share by Type (2012-2017)
Figure Africa Drug Eluting Stents (DES) Sales Market Share by Type in 2016
Table Africa Drug Eluting Stents (DES) Sales (K Units) by Application (2012-2017)
Table Africa Drug Eluting Stents (DES) Sales Market Share by Application (2012-2017)
Figure Africa Drug Eluting Stents (DES) Sales Market Share by Application (2012-2017)
Table Africa Drug Eluting Stents (DES) Sales Volume (K Units) by Countries (2012-2017)
Table Africa Drug Eluting Stents (DES) Sales Market Share by Countries (2012-2017)
Figure Africa Drug Eluting Stents (DES) Sales Market Share by Countries (2012-2017)
Figure Africa Drug Eluting Stents (DES) Sales Market Share by Countries in 2016
Table Africa Drug Eluting Stents (DES) Revenue (Million USD) by Countries (2012-2017)
Table Africa Drug Eluting Stents (DES) Revenue Market Share by Countries (2012-2017)
Figure Africa Drug Eluting Stents (DES) Revenue Market Share by Countries (2012-2017)
Figure Africa Drug Eluting Stents (DES) Revenue Market Share by Countries in 2016
Figure South Africa Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Table Abbott Vascular Drug Eluting Stents (DES) Basic Information List
Table Abbott Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Vascular Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure Abbott Vascular Drug Eluting Stents (DES) Sales Market Share in EMEA (2012-2017)
Figure Abbott Vascular Drug Eluting Stents (DES) Revenue Market Share in EMEA (2012-2017)
Table Advantec Vascular Drug Eluting Stents (DES) Basic Information List
Table Advantec Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Advantec Vascular Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure Advantec Vascular Drug Eluting Stents (DES) Sales Market Share in EMEA (2012-2017)
Figure Advantec Vascular Drug Eluting Stents (DES) Revenue Market Share in EMEA (2012-2017)
Table B.Braun Melsengen AG Drug Eluting Stents (DES) Basic Information List
Table B.Braun Melsengen AG Drug Eluting Stents (DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure B.Braun Melsengen AG Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure B.Braun Melsengen AG Drug Eluting Stents (DES) Sales Market Share in EMEA (2012-2017)
Figure B.Braun Melsengen AG Drug Eluting Stents (DES) Revenue Market Share in EMEA (2012-2017)
Table Biosensors Drug Eluting Stents (DES) Basic Information List
Table Biosensors Drug Eluting Stents (DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biosensors Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure Biosensors Drug Eluting Stents (DES) Sales Market Share in EMEA (2012-2017)
Figure Biosensors Drug Eluting Stents (DES) Revenue Market Share in EMEA (2012-2017)
Table Biotronik Drug Eluting Stents (DES) Basic Information List
Table Biotronik Drug Eluting Stents (DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biotronik Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure Biotronik Drug Eluting Stents (DES) Sales Market Share in EMEA (2012-2017)
Figure Biotronik Drug Eluting Stents (DES) Revenue Market Share in EMEA (2012-2017)
Table Blue Medical Drug Eluting Stents (DES) Basic Information List
Table Blue Medical Drug Eluting Stents (DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Blue Medical Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure Blue Medical Drug Eluting Stents (DES) Sales Market Share in EMEA (2012-2017)
Figure Blue Medical Drug Eluting Stents (DES) Revenue Market Share in EMEA (2012-2017)
Table Boston Scientific Drug Eluting Stents (DES) Basic Information List
Table Boston Scientific Drug Eluting Stents (DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boston Scientific Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure Boston Scientific Drug Eluting Stents (DES) Sales Market Share in EMEA (2012-2017)
Figure Boston Scientific Drug Eluting Stents (DES) Revenue Market Share in EMEA (2012-2017)
Table DISA Vascular Drug Eluting Stents (DES) Basic Information List
Table DISA Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure DISA Vascular Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure DISA Vascular Drug Eluting Stents (DES) Sales Market Share in EMEA (2012-2017)
Figure DISA Vascular Drug Eluting Stents (DES) Revenue Market Share in EMEA (2012-2017)
Table Essen Drug Eluting Stents (DES) Basic Information List
Table Essen Drug Eluting Stents (DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Essen Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure Essen Drug Eluting Stents (DES) Sales Market Share in EMEA (2012-2017)
Figure Essen Drug Eluting Stents (DES) Revenue Market Share in EMEA (2012-2017)
Table Medtronic Vascular Drug Eluting Stents (DES) Basic Information List
Table Medtronic Vascular Drug Eluting Stents (DES) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Medtronic Vascular Drug Eluting Stents (DES) Sales (K Units) and Growth Rate (2012-2017)
Figure Medtronic Vascular Drug Eluting Stents (DES) Sales Market Share in EMEA (2012-2017)
Figure Medtronic Vascular Drug Eluting Stents (DES) Revenue Market Share in EMEA (2012-2017)
Table MicroPort Medical Drug Eluting Stents (DES) Basic Information List
Table MIV Therapeutics Drug Eluting Stents (DES) Basic Information List
Table Orbusneich Drug Eluting Stents (DES) Basic Information List
Table Promed Medical Drug Eluting Stents (DES) Basic Information List
Table Relisys Medical Drug Eluting Stents (DES) Basic Information List
Table Reva Medical Drug Eluting Stents (DES) Basic Information List
Table Sahajanand Drug Eluting Stents (DES) Basic Information List
Table Sino Medical Drug Eluting Stents (DES) Basic Information List
Table Sorin Drug Eluting Stents (DES) Basic Information List
Table Terumo Medical Drug Eluting Stents (DES) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drug Eluting Stents (DES)
Figure Manufacturing Process Analysis of Drug Eluting Stents (DES)
Figure Drug Eluting Stents (DES) Industrial Chain Analysis
Table Raw Materials Sources of Drug Eluting Stents (DES) Major Manufacturers in 2016
Table Major Buyers of Drug Eluting Stents (DES)
Table Distributors/Traders List
Figure EMEA Drug Eluting Stents (DES) Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Drug Eluting Stents (DES) Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Drug Eluting Stents (DES) Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Drug Eluting Stents (DES) Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Drug Eluting Stents (DES) Sales Market Share Forecast by Region (2017-2022)
Table EMEA Drug Eluting Stents (DES) Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Drug Eluting Stents (DES) Revenue Market Share Forecast by Region (2017-2022)
Table Europe Drug Eluting Stents (DES) Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Drug Eluting Stents (DES) Sales Market Share Forecast by Countries (2017-2022)
Table Europe Drug Eluting Stents (DES) Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Drug Eluting Stents (DES) Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Drug Eluting Stents (DES) Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Drug Eluting Stents (DES) Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Drug Eluting Stents (DES) Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Drug Eluting Stents (DES) Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Drug Eluting Stents (DES) Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Drug Eluting Stents (DES) Sales Market Share Forecast by Countries (2017-2022)
Table Africa Drug Eluting Stents (DES) Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Drug Eluting Stents (DES) Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Drug Eluting Stents (DES) Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Drug Eluting Stents (DES) Sales Market Share Forecast by Type (2017-2022)
Table EMEA Drug Eluting Stents (DES) Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Drug Eluting Stents (DES) Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources